PRESSR: Precision Health: Redefining the future of healthcare

Imagine a world where healthcare treatments are tailored to your unique genetic profile and lifestyle choices, maximizing their effectiveness and minimizing side effects. This is the promise of precision health, a rapidly evolving field that is transforming healthcare globally.

Traditionally, clinical practice has relied on a one-size-fits-all approach, treating diseases with broad-spectrum therapies. Precision health takes a more individualized approach. By analyzing a patient's genes, environment, and lifestyle – factors relevant to our health and disease history - doctors can gain a deeper understanding of their specific condition and likely response to treatment.

Doctors can now implement targeted preventive measures for their patients, including pharmacogenomics, or customized treatments based on understanding how an individual's genetic profile affects their responses to drugs. Prescribing precise drugs at precise doses to meet the unique needs of each patient marks a significant difference compared to traditional healthcare.

One of the key benefits of precision health is its potential to shift healthcare from a reactive to a proactive model by identifying individuals at high risk for specific diseases based on their genetic makeup. Tailored screening protocols can help physicians initiate early detection and intervention strategies, potentially preventing disease progression.

Qatar has been pioneering precision health in the region for close to a decade and aims to transform the way clinical screening is done for hereditary conditions such as cancer, diabetes, and autism, including screening for variants specific to the Qatari and Middle Eastern populations.

Arab populations have historically been underrepresented in genomic research due to a lack of datasets, a gap that is prevalent in current studies that focus on gene pools from Western countries. With genetic diagnosis based on actual population data, results are likely to be more relevant and accurate, leading to improved healthcare outcomes for the people of Qatar and beyond.

Precision health represents a paradigm shift in healthcare, offering personalized approaches to treatment and prevention that have the potential to revolutionize the cost and effectiveness of public healthcare on a global scale. Using the insights gained from genetic and lifestyle data, healthcare providers can empower individuals to make informed decisions about their health, ultimately leading to healthier lives and a healthier society.

Looking towards the future and with the rapid advancements in technology, our understanding of the human genome will continue to deepen, helping us explore the endless possibilities for precision health. With Qatar’s commitment to bringing these personalized therapies and preventative strategies into clinical settings, the positive impact will be felt through a better quality of life and well-being.

-Ends-

About QPHI

Qatar Precision Health Institute (QPHI) is a national center for research and implementation under Qatar Foundation.

Its primary focus is to enhance precision healthcare quality and value through comprehensive study of genomics and multi-omics.

QPHI was conceptualized to leverage more than 10 years of valuable data collection, research, and ecosystem development accomplished by Qatar Biobank and Qatar Genome. The goal is to lead in preventing and curing health issues through personalized approaches, and consequently empower and enable precision health practices leading to healthy and vibrant communities.

© Press Release 2024

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.